Scientific Opinion on the substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006
<p>Following an application from Nutrilinks Sarl, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinio...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-07-01
|
| Series: | EFSA Journal |
| Subjects: | |
| Online Access: | http://www.efsa.europa.eu/en/efsajournal/doc/2803.pdf |
| _version_ | 1830308745565962240 |
|---|---|
| author | EFSA Panel on Dietetic Products, Nutrition and Allergies |
| author_facet | EFSA Panel on Dietetic Products, Nutrition and Allergies |
| author_sort | EFSA Panel on Dietetic Products, Nutrition and Allergies |
| collection | DOAJ |
| description | <p>Following an application from Nutrilinks Sarl, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations. The food that is the subject of the health claim, <em>Opti</em><sub>EFAX</sub>&trade;, which is standardised pure krill oil, is sufficiently characterised in relation to the claimed effect. The claimed effect, maintenance of normal blood HDL-cholesterol concentrations, is a beneficial physiological effect. The target population proposed by the applicant is the general population. No human studies have been provided from which conclusions could be drawn for the scientific substantiation of the claim. A cause and effect relationship has not been established between the consumption of <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations.</p> |
| first_indexed | 2024-12-19T10:54:51Z |
| format | Article |
| id | doaj.art-854eadf388f549ffb93567442b4446e8 |
| institution | Directory Open Access Journal |
| issn | 1831-4732 |
| language | English |
| last_indexed | 2024-12-19T10:54:51Z |
| publishDate | 2012-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | EFSA Journal |
| spelling | doaj.art-854eadf388f549ffb93567442b4446e82022-12-21T20:24:51ZengWileyEFSA Journal1831-47322012-07-0110710.2903/j.efsa.2012.2803Scientific Opinion on the substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006EFSA Panel on Dietetic Products, Nutrition and Allergies<p>Following an application from Nutrilinks Sarl, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations. The food that is the subject of the health claim, <em>Opti</em><sub>EFAX</sub>&trade;, which is standardised pure krill oil, is sufficiently characterised in relation to the claimed effect. The claimed effect, maintenance of normal blood HDL-cholesterol concentrations, is a beneficial physiological effect. The target population proposed by the applicant is the general population. No human studies have been provided from which conclusions could be drawn for the scientific substantiation of the claim. A cause and effect relationship has not been established between the consumption of <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations.</p>http://www.efsa.europa.eu/en/efsajournal/doc/2803.pdfOptiEFAX™krill oilHDLcholesterolhealth claims |
| spellingShingle | EFSA Panel on Dietetic Products, Nutrition and Allergies Scientific Opinion on the substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006 EFSA Journal OptiEFAX™ krill oil HDL cholesterol health claims |
| title | Scientific Opinion on the substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| title_full | Scientific Opinion on the substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| title_fullStr | Scientific Opinion on the substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| title_full_unstemmed | Scientific Opinion on the substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| title_short | Scientific Opinion on the substantiation of a health claim related to <em>Opti</em><sub>EFAX</sub>&trade; and maintenance of normal blood HDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| title_sort | scientific opinion on the substantiation of a health claim related to lt em gt opti lt em gt lt sub gt efax lt sub gt amp trade and maintenance of normal blood hdl cholesterol concentrations pursuant to article 13 5 of regulation ec no 1924 2006 |
| topic | OptiEFAX™ krill oil HDL cholesterol health claims |
| url | http://www.efsa.europa.eu/en/efsajournal/doc/2803.pdf |
| work_keys_str_mv | AT efsapanelondieteticproductsnutritionandallergies scientificopiniononthesubstantiationofahealthclaimrelatedtoltemgtoptiltemgtltsubgtefaxltsubgtamptradeandmaintenanceofnormalbloodhdlcholesterolconcentrationspursuanttoarticle135ofregulationecno19242006 |